Telerobotic surgery is moving from experimental to practical, with medtech companies preparing for a future where a surgeon can operate on a patient from hundreds of miles away. The technology promises to expand access to specialized care, especially in rural or underserved areas. Yet, according to Healthcare Dive, the US has been slower to embrace it compared to other regions.
While the source highlights global advances, it notes that US adoption is not guaranteed. Regulatory approval, liability concerns, and reimbursement policies remain significant barriers. The article suggests that without clear federal guidance and payment models, hospitals may hesitate to invest in telesurgery systems, even as international trials show feasibility.
No conflicting sources were provided, so the analysis rests solely on Healthcare Dive's reporting. The key takeaway is that telesurgery's potential is real, but its US future depends on resolving systemic issues beyond the technology itself.